Entegris, Inc. ENTG
Composite 44/100; the shares have moved about 78% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 22/100 — a strong mark against it.
Balance-sheet strength ranks 61/100 — a slight point in its favour. Momentum ranks 56/100 — a slight point in its favour.
Valuation ranks 22/100 — a strong mark against it. Growth ranks 34/100 — a moderate mark against it. Income ranks 36/100 — a moderate mark against it.
What the company does Entegris provides advanced materials and process solutions for semiconductor and high-tech industries, including materials for deposition, planarization, filtration, and contamination control. Its customers span logic/memory chipmakers, equipment suppliers, and adjacent sectors like solar and life sciences.
Key financials Entegris reports gross margins of 44.8% and net margins of 8.2%, with revenue growth of 5.0% and EPS growth of 46.3%. ROE is 6.8%, ROA 3.8%, and ROCE 6.0%. Debt/equity is 0.93, net debt/EBITDA 3.76, and interest coverage 2.44.
Stock health The stock shows mixed momentum: down 21.53% over 3 months, down 2.78% over 6 months, but up 26.70% over 12 months. It is 37.30% below its 52-week high, with RSI(14) at 38.70. Sideravia scores it Weak quality (39.6) and richly valued (25.2).
Price vs fair value The stock trades at a PREMIUM of 59.00% to our fair-value estimate of 47.96 and at a discount of 41.75% to the analyst 12-month target of 166.00. - Recent Zacks coverage highlights expected Q2 earnings beats and growth ahead of release (Zacks). - Analysts cite strong forward P/E of 36.63 and PEG of 0.35 as supporting upside potential. - High valuation multiples (P/E 74.65, EV/EBITDA 27.10) temper near-term sentiment.
Looking forward Forward estimates imply significant earnings growth, but current valuation and weak quality scores suggest limited margin of safety. Investors should monitor Q2 results and management commentary for execution clarity.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.